ICVX insider filings

Icosavax, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-02-20. Screen ICVX transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for ICVX between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Icosavax, Inc.

FiledFormInsiderReported transactionsSource
2024-02-204Simpson Adam K.Code (U): 358,657 · Code (U): 525,044 · Code (U): 129,032 · Code (U): 129,032 · Disposition to issuer (D): 191,449 (derivative) · Disposition to issuer (D): 237,146 (derivative) · +4 moreEDGAR
2024-02-204Khan AminDisposition to issuer (D): 120,000 (derivative) · Disposition to issuer (D): 180,000 (derivative)EDGAR
2024-02-204Cearley CassiaCode (U): 131,799 · Disposition to issuer (D): 2,511 (derivative) · Disposition to issuer (D): 104,204 (derivative) · Disposition to issuer (D): 100,000 (derivative) · Disposition to issuer (D): 180,474 (derivative) · Disposition to issuer (D): 140,000 (derivative) · +2 moreEDGAR
2024-02-204Wassil JimCode (U): 3,695 · Disposition to issuer (D): 7,392 · Disposition to issuer (D): 44,556 (derivative) · Disposition to issuer (D): 17,000 (derivative)EDGAR
2024-02-204Russo Thomas JosephCode (U): 39,367 · Disposition to issuer (D): 100,000 (derivative) · Disposition to issuer (D): 376,590 (derivative) · Disposition to issuer (D): 125,000 (derivative) · Disposition to issuer (D): 97,500 (derivative) · Disposition to issuer (D): 74,500 (derivative)EDGAR
2024-02-204Shiver John W.Code (U): 8,066 · Disposition to issuer (D): 2,833 · Disposition to issuer (D): 9,643 (derivative) · Disposition to issuer (D): 17,000 (derivative) · Disposition to issuer (D): 25,500 (derivative)EDGAR
2024-02-204Kanesa-thasan NiranjanCode (U): 223,980 · Disposition to issuer (D): 2,511 (derivative) · Disposition to issuer (D): 42,193 (derivative) · Disposition to issuer (D): 82,580 (derivative) · Disposition to issuer (D): 108,369 (derivative) · Disposition to issuer (D): 110,000 (derivative) · +2 moreEDGAR
2024-02-204Veneman Ann MCode (U): 11,209 · Disposition to issuer (D): 2,834 · Disposition to issuer (D): 22,278 (derivative) · Disposition to issuer (D): 17,000 (derivative) · Disposition to issuer (D): 25,500 (derivative)EDGAR
2024-02-204RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner
RA Capital Healthcare Fund LP — Director, 10% owner
RA Capital Nexus Fund II, L.P. — Director, 10% owner
Kolchinsky Peter — Director, 10% owner
Shah Rajeev M. — Director, 10% owner
Code (U): 5,543 · Code (U): 5,324,897 · Code (U): 638,668 · Disposition to issuer (D): 22,278 (derivative) · Disposition to issuer (D): 17,000 (derivative)EDGAR
2024-02-204MCDADE MARKCode (U): 55,786 · Code (U): 3,510,228 · Disposition to issuer (D): 22,278 (derivative) · Disposition to issuer (D): 17,000 (derivative)EDGAR
2024-02-204FIELDS HEIDICode (U): 11,376 · Disposition to issuer (D): 2,917 · Disposition to issuer (D): 22,278 (derivative) · Disposition to issuer (D): 25,266 (derivative) · Disposition to issuer (D): 17,000 (derivative)EDGAR
2024-02-024Simpson Adam K. — Chief Executive Officer, DirectorGift (G): 6,532 @ $0 · Option exercise (M): 15,000 @ $1.04 · Sale (S): 15,000 @ $15.29 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2024-01-234Simpson Adam K. — Chief Executive Officer, DirectorOption exercise (M): 4,789 @ $0.84 · Option exercise (M): 93,227 @ $1.04 · Option exercise (M): 4,789 (derivative) @ $0 · Option exercise (M): 93,227 (derivative) @ $0EDGAR
2024-01-054Kanesa-thasan Niranjan — Chief Medical OfficerOption exercise (M): 13,806 @ $0.84 · Option exercise (M): 74,648 @ $1.04 · Option exercise (M): 11,947 @ $5.90 · Option exercise (M): 5,972 @ $15 · Sale (S): 106,373 @ $15.70 · Option exercise (M): 13,806 (derivative) @ $0 · +3 moreEDGAR
2024-01-044Simpson Adam K. — Chief Executive Officer, DirectorOption exercise (M): 15,000 @ $1.04 · Sale (S): 15,000 @ $15.67 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2023-12-224Simpson Adam K. — Chief Executive Officer, DirectorSale (S): 62,205 @ $15.46 · Option exercise (M): 102,574 @ $1.04 · Option exercise (M): 40,000 @ $2.47 · Option exercise (M): 23,343 @ $0.84 · Sale (S): 50,000 @ $15.44 · Sale (S): 40,000 @ $15.43 · +3 moreEDGAR
2023-12-224Russo Thomas Joseph — Chief Financial OfficerSale (S): 10,753 @ $15.46 · Sale (S): 4,430 @ $15.46EDGAR
2023-12-224Kanesa-thasan Niranjan — Chief Medical OfficerSale (S): 11,884 @ $15.46EDGAR
2023-12-224Cearley Cassia — Chief Business OfficerSale (S): 7,934 @ $15.46EDGAR
2023-12-154Cearley Cassia — Chief Business OfficerSale (S): 8,759 @ $16.01EDGAR
2023-08-014Simpson Adam K. — Chief Executive Officer, DirectorOption exercise (M): 3,000 @ $0.84 · Option exercise (M): 3,000 (derivative) @ $0EDGAR
2023-08-014Kanesa-thasan Niranjan — Chief Medical OfficerSale (S): 3,323 @ $8.86EDGAR
2023-08-014Simpson Adam K. — Chief Executive Officer, DirectorSale (S): 11,788 @ $8.86EDGAR
2023-08-014Russo Thomas Joseph — Chief Financial OfficerSale (S): 3,066 @ $8.86EDGAR
2023-08-014Cearley Cassia — Chief Business OfficerSale (S): 1,888 @ $8.86EDGAR
2023-07-034Holtzman Douglas — Chief Scientific OfficerOption exercise (M): 16,356 @ $1.04 · Sale (S): 14,261 @ $8.74 · Sale (S): 2,095 @ $9.59 · Option exercise (M): 16,356 (derivative) @ $0EDGAR
2023-06-144Khan Amin — EVP, Head of Research & Dev.Grant/award (A): 180,000 (derivative) @ $0EDGAR
2023-06-084Wassil Jim — DirectorGrant/award (A): 17,000 (derivative) @ $0EDGAR
2023-06-084Shiver John W. — DirectorGrant/award (A): 17,000 (derivative) @ $0EDGAR
2023-06-084Veneman Ann M — DirectorGrant/award (A): 17,000 (derivative) @ $0EDGAR
2023-06-084RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner
RA Capital Healthcare Fund LP — Director, 10% owner
RA Capital Nexus Fund, L.P. — Director, 10% owner
Kolchinsky Peter — Director, 10% owner
Shah Rajeev M. — Director, 10% owner
Grant/award (A): 17,000 (derivative) @ $0EDGAR
2023-06-084MCDADE MARK — DirectorGrant/award (A): 17,000 (derivative) @ $0EDGAR
2023-06-084FIELDS HEIDI — DirectorGrant/award (A): 17,000 (derivative) @ $0EDGAR
2023-05-254Cearley Cassia — Chief Business OfficerSale (S): 10,000 @ $10EDGAR
2023-04-054Holtzman Douglas — Chief Scientific OfficerOption exercise (M): 20,443 @ $1.04 · Sale (S): 20,143 @ $6.08 · Sale (S): 300 @ $6.56 · Option exercise (M): 20,443 (derivative) @ $0EDGAR
2023-03-084Cearley Cassia — Chief Business OfficerSale (S): 5,000 @ $7.75EDGAR
2023-02-174Russo Thomas Joseph — Chief Financial OfficerGrant/award (A): 125,000 (derivative) @ $0EDGAR
2023-02-174Bekiroglu Elizabeth — General Counsel & Corp. Sec.Grant/award (A): 100,000 (derivative) @ $0EDGAR
2023-02-174Kanesa-thasan Niranjan — Chief Medical OfficerGrant/award (A): 110,000 (derivative) @ $0EDGAR
2023-02-174Holtzman Douglas — Chief Scientific OfficerGrant/award (A): 90,000 (derivative) @ $0EDGAR
2023-02-174Cearley Cassia — Chief Business OfficerGrant/award (A): 140,000 (derivative) @ $0EDGAR
2023-02-174Simpson Adam K. — Chief Executive Officer, DirectorGrant/award (A): 350,000 (derivative) @ $0EDGAR
2023-02-164Simpson Adam K. — Chief Executive Officer, DirectorOption exercise (M): 10,677 @ $1.04 · Option exercise (M): 10,677 (derivative) @ $0EDGAR
2023-02-154Bekiroglu Elizabeth — General Counsel & Corp. Sec.Sale (S): 5,922 @ $10.69EDGAR
2023-02-154Simpson Adam K. — Chief Executive Officer, DirectorSale (S): 7,506 @ $10.69EDGAR
2023-02-154Holtzman Douglas — Chief Scientific OfficerSale (S): 1,522 @ $10.69 · Sale (S): 3,349 @ $10.17EDGAR
2023-02-154Russo Thomas Joseph — Chief Financial OfficerSale (S): 1,902 @ $10.69EDGAR
2023-02-154Kanesa-thasan Niranjan — Chief Medical OfficerSale (S): 1,794 @ $10.69EDGAR
2023-02-154Cearley Cassia — Chief Business OfficerSale (S): 1,660 @ $10.69EDGAR
2023-01-314Cearley Cassia — Chief Business OfficerOption exercise (M): 25,102 @ $0.84 · Option exercise (M): 25,102 (derivative) @ $0EDGAR

Recent 8-K events — Icosavax, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2024-02-208-K2.01 — Completion of Acquisition or Disposition of Assets
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2023-12-128-K1.01 — Entry into a Material Definitive Agreement
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2023-11-148-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2023-08-148-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2023-08-088-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2023-06-098-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2023-05-238-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2023-05-228-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2023-05-108-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2023-03-308-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=ICVX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs